Form 4: Tempest Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Nancy Freda Smith, a Director of Tempest Therapeutics, Inc., received 25,000 shares of common stock on September 22, 2026.
Summary
- Grant/award: acquired 25,000 Stock Option (right to buy) on September 22, 2026; holds 25,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Nancy Freda Smith — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-22 | Grant/award | Stock Option (right to buy) | 25,000 | — | — | 25,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-22 | Grant/award (25,000 shares) |
Keywords
insider transaction, Form 4, TPST, Tempest Therapeutics, Inc., neutral, Nancy Freda Smith
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.